Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steady-state bioequivalence crossover study of Mylan efavirenz versus Sustiva in adults with HIV-1
2015-003278-34Phase 4Terminated
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoints: AUC(0-24h) and Cmaxss. Started Jun 2021; status: terminated.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2015-003278-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003278-34.